Geben Sie eine Aktie oder eine Kryptowährung in der Suchleiste an, um eine Zusammenfassung zu erhalten
Advanced Medical Solutions Group plc
AMSAdvanced Medical Solutions Group plc, together with its subsidiaries, develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. It operates in two segments, Surgical and Woundcare. The company offers surgical products, such as tissue adhesives, sutures, haemostats, internal fixation devices, and internal sealants under LiquiBand, RESORBA, LiquiBandFix8, LIQUIFIX, and Seal-G brand names. It also provides wound care dressings, including silver alginates, alginates, and foams through its ActivHeal brand, as well as under white label. Advanced Medical Solutions Group plc was founded in 1991 and is headquartered in Winsford, the United Kingdom. Address: Premier Park, Winsford, United Kingdom, CW7 3RT
Analytics
Zielpreis von Wall Street
19 749.36 GBXKGV
43.9Dividendenrendite
1.13 %Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Schlüsselzahlen AMS
Dividenden-Analyse AMS
Dividendenwachstum über 5 Jahre
89 %Kontinuierliches Wachstum
5 JahreAusschüttungsquote 5-Jahres-Durchschnitt
2623 %Verlauf der Dividende AMS
Bewertung der Aktie AMS
Finanzen AMS
Ergebnisse | 2019 | Dynamik |